The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia

BACKGROUND: Hemodialysis (HD) patients with functional iron deficiency often develop resistance to recombinant human erythropoietin (rhEPO). Recent studies have shown that intravenous ascorbic acid (IVAA) administration could override rhEPO resistance in HD patients. This study was undertaken to tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dae Woong, Ahn, Chi Yong, Ryu, Bong Kwan, Shin, Byung Chul, Chung, Jong Hoon, Kim, Hyun Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715092/
https://www.ncbi.nlm.nih.gov/pubmed/26889408
http://dx.doi.org/10.1016/j.krcp.2012.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715092/
https://www.ncbi.nlm.nih.gov/pubmed/26889408
http://dx.doi.org/10.1016/j.krcp.2012.01.002

Ejemplares similares